Amryt Pharma plc (LON:AMYT – Get Free Report) shares passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 143 ($1.88) and traded as low as GBX 143 ($1.88). Amryt Pharma shares last traded at GBX 143 ($1.88), with a volume of 90,726 shares traded.
Amryt Pharma Stock Performance
The company has a market cap of £457.11 million and a PE ratio of -4.33. The stock has a 50 day simple moving average of GBX 143 and a two-hundred day simple moving average of GBX 143. The company has a debt-to-equity ratio of 66.05, a current ratio of 1.80 and a quick ratio of 1.14.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Further Reading
- Five stocks we like better than Amryt Pharma
- What Makes a Stock a Good Dividend Stock?
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Airline Stocks – Top Airline Stocks to Buy Now
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- What is the Dogs of the Dow Strategy? Overview and Examples
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
